Precision BioLogic originally developed CRYOcheck Chromogenic Factor VIII in response to a growing demand for chromogenic assays 1. Launched in 2020, it was the first commercially available, ...
The first part of this article discussed general strategies for validation extensions to other test method components, laboratories and even different test methods.1 This second part provides ...
Please provide your email address to receive an email when new articles are posted on . CHICAGO — In stable symptomatic patients with suspected CAD, a precision testing strategy was linked to a 70% ...
GLEN ALLEN, Va., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for ...
The COVID-19 pandemic and the recent rise in global cases of monkeypox and other infectious diseases have brought human immunology into the spotlight. Understanding how our bodies fight invaders and ...
This summary provides an overview of the most significant critical numbers from each of the Chunghwa Precision Test financial reports, including the Chunghwa Precision Test Tech Co Ltd income ...
HALIFAX, NS, Sept. 10, 2025 /CNW/ - Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce the expanded utility of its CRYOcheck Chromogenic Factor VIII ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback